US2005048096A1PendingUtilityA1

Crosslinking of polyethylene for low wear using radiation and thermal treatments

Priority: Jul 9, 1996Filed: Sep 7, 2004Published: Mar 3, 2005
Est. expiryJul 9, 2016(expired)· nominal 20-yr term from priority
B29C 71/02B29C 2035/085Y10S525/937B29K 2995/0087A61F 2002/3611B29L 2031/7532A61F 2002/3429A61F 2/34C08J 7/123C08J 3/28B29C 43/00A61F 2/32C08J 2323/06B29K 2995/0089B29K 2023/0683A61F 2/30767B29C 71/04A61F 2/3094C08J 7/08B29C 2071/022A61L 27/16A61F 2002/3414B29C 43/16A61F 2002/30084B29K 2023/0675A61F 2/468
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention discloses methods for enhancing the wear-resistance of polymers, the resulting polymers, and in vivo implants made from such polymers. One aspect of this invention presents a method whereby a polymer is irradiated, preferably with gamma radiation, then thermally treated, such as by remelting of annealing. The resulting polymeric composition preferably has its most oxidized surface layer removed. Another aspect of the invention presents a general method for optimizing the wear resistance and desirable physical and/or chemical properties of a polymer by crosslinking and thermally treating it. The resulting polymeric compositions is wear-resistant and may be fabricated into an in vivo implant.

Claims

exact text as granted — not AI-modified
1 . A preformed polymeric composition comprising a crosslinked thermally treated polymer.  
     
     
         2 . The composition of  claim 1 , wherein the composition possesses one or more of the following characteristics: degree of swelling of between about 1.7 to about 5.3; molecular weight between crosslinks of between about 400 to about 8400 g/mol; and a gel content of between about 95 to about 99%.  
     
     
         3 . The composition of  claim 1 , wherein the preformed polymeric composition is crosslinked by gamma radiation at a dose from about 1 to about 100 Mrad.  
     
     
         4 . The composition of  claim 3 , wherein the dose is from about 5 to about 25 Mrad.  
     
     
         5 . An in vivo implant comprising a crosslinked and remelted polymer.  
     
     
         6  to  30 . (canceled).

Join the waitlist — get patent alerts

Track US2005048096A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.